The hidden evolution inside your immune system, and what it means for vaccines
Every time you fight an infection or respond to a vaccine, your immune system runs a miniature evolutionary competition. The cells that produce better antibodies win and multiply. But the exact rules of this competition were unknown, until now.
When the body encounters a pathogen, B cells, a type of white blood cell, do more than simply produce antibodies. Inside structures called germinal centres, tiny oval nodes found in lymph nodes and the spleen, B cells undergo an accelerated evolutionary process. They mutate rapidly, and the variants that bind more tightly to the invading pathogen, or to a vaccine protein, are selectively amplified. The result is a progressive refinement of antibody quality, tuned precisely to the current threat.
This process, known as affinity maturation, is fundamental to a strong and lasting immune response. It is also why vaccines typically require multiple doses: each repeated exposure drives another round of selection and improvement. But the precise mathematics underlying this process, how much does stronger binding actually increase a B cell’s chances of producing more offspring?, remained unknown. Researchers refer to this relationship as the ‘affinity–fitness response function’, and until now, no one had been able to determine its shape.
Using simulation as a microscope
The research team developed an approach they call simulation-based deep learning. They built detailed computer models of germinal centres, ran those simulations under varying assumptions about the affinity–fitness relationship, and then trained a neural network to identify which simulated scenarios best matched real biological data from actual B cells. This allowed them to infer the unknown response function without having to measure it directly, a significant technical achievement.
The implications for vaccine design are direct. Knowing how strongly affinity-based selection operates inside germinal centres makes it possible to engineer vaccine antigens that drive this selection more efficiently, producing high-quality, long-lived antibody responses more reliably. This is particularly relevant for vaccines against rapidly mutating viruses like influenza or future SARS variants, where the demands on antibody quality are exceptionally high.
A method with reach beyond this finding
The methodological contribution may be as significant as the specific result. Simulation-based inference, using computational models to estimate biological parameters that cannot be measured directly, is an emerging technique with applications across multiple areas of biology. Combined with deep learning, it becomes capable of mapping complex, non-linear processes that traditional mathematical approaches struggle to capture.
Germinal centres are also implicated in autoimmune disease: when the selection process goes wrong, B cells can produce antibodies that attack the body’s own tissues. A deeper understanding of the evolutionary dynamics in these structures could therefore yield insights relevant to conditions like lupus or rheumatoid arthritis, though translating that understanding into clinical applications remains a long-term prospect.